Telesis Bio Inc. Quarterly Selling and Marketing Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Telesis Bio Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2020 to Q2 2024.
  • Telesis Bio Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $1.7M, a 46.8% decline year-over-year.
  • Telesis Bio Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $9.89M, a 35.2% decline year-over-year.
  • Telesis Bio Inc. annual Selling and Marketing Expense for 2023 was $13.5M, a 18% decline from 2022.
  • Telesis Bio Inc. annual Selling and Marketing Expense for 2022 was $16.5M, a 50.5% increase from 2021.
  • Telesis Bio Inc. annual Selling and Marketing Expense for 2021 was $11M, a 58.1% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.89M $1.7M -$1.49M -46.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.4M $1.68M -$2.13M -56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $13.5M $3.77M -$294K -7.23% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $13.8M $2.74M -$1.45M -34.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $15.3M $3.19M -$1.5M -31.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $16.8M $3.81M +$261K +7.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $16.5M $4.07M +$968K +31.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $15.5M $4.19M +$1.23M +41.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $14.3M $4.69M +$2.06M +78.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $12.2M $3.55M +$1.27M +55.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $11M $3.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $2.96M +$1.09M +58.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.63M +$1.03M +64.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $2.28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $1.86M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.